Soleus Capital Management »

Nektar Therapeutics shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.0M 128k 69.81

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Celcuity (CELC)
Tg Therapeutics (TGTX)
Insulet Corporation (PODD)
Novocure Ord Shs (NVCR)
United Therapeutics Corporation (UTHR)
Inspire Med Sys (INSP)
Rigel Pharmaceuticals (RIGL)
Biosante Pharmaceuticals (ANIP)
Beta Bionics (BBNX)
Vericel (VCEL)
Praxis Precision Medicines I Com New (PRAX)
Geron Corporation (GERN)
Alkermes SHS (ALKS)
Erasca (ERAS)

View all positions for Soleus Capital Management

Top funds holding Nektar Therapeutics

FMR
Two Seas Capital
BlackRock
BVF
Susquehanna International
Vanguard Capital Management
Two Sigma Investments
Vestal Point Capital
Geode Capital Management
Prosight Management
Armistice Capital
Morgan Stanley
Millennium Management
Gilder, Gagnon, Howe & Co
Citadel Advisors

View all funds holding Nektar Therapeutics